However, in pre-clinical studies, FX11—a derivative of AT-101 that selectively inhibits LDHA over LDHB—effectively inhibited tumorigenesis in vivo using human lymphoma and pancreatic tumor xenograft models (38). Here, LDHA is linked to pancreatic neoplasm.